“merck” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup 08/11/20 San Diego
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations 05/27/20 New York
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won’t Delay Data 04/10/20 National
Menlo’s Itching Drug Racks Up Two More Trial Failures, Program Ends 04/06/20 New York
Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel 03/26/20 Boston
Page 1 of 29 next page »